Bangkok Genomics Innovation PCL (BKK:BKGI) EPS (Basic): ฿0.08 (TTM As of Dec. 2025)


BKK:BKGI Bangkok Genomics Innovation PCL BKK:BKGI
45 GF Score
Price ฿2.08
! 12 Warning Signs
View Full Analysis

What is Bangkok Genomics Innovation PCL EPS (Basic)?

Bangkok Genomics Innovation PCL BKK:BKGI 45 EPS (Basic) is ฿0.08 as of Dec. 2025. GuruFocus rates BKK:BKGI with a GF Score™ of 45/100. The stock has 12 warning signs investors should review.

Bangkok Genomics Innovation PCL's basic earnings per share (Basic EPS) for the three months ended in Dec. 2025 was ฿0.04. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was ฿0.08.

Bangkok Genomics Innovation PCL's EPS (Diluted) for the three months ended in Dec. 2025 was ฿0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was ฿0.08.

Bangkok Genomics Innovation PCL's EPS without NRI for the three months ended in Dec. 2025 was ฿0.04. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 0.08.

During the past 12 months, Bangkok Genomics Innovation PCL's average EPS without NRIGrowth Rate was -13.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was -15.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Bangkok Genomics Innovation PCL's highest 3-Year average EPS without NRI Growth Rate was 32.90% per year. The lowest was -20.60% per year. And the median was -15.30% per year.

Bangkok Genomics Innovation PCL  (BKK:BKGI) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Bangkok Genomics Innovation PCL EPS (Basic) Related Terms

Bangkok Genomics Innovation PCL EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Bangkok Genomics Innovation PCL's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bangkok Genomics Innovation PCL EPS (Basic) Chart

Bangkok Genomics Innovation PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial 0.24 0.17 0.05 0.09 0.08

Bangkok Genomics Innovation PCL Quarterly Data
Dec19 Dec20 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.01 0.01 0.04
BKK:BKGI
45GF Score
Bangkok Genomics Innovation PCL BKK:BKGI
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bangkok Genomics Innovation PCL EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Bangkok Genomics Innovation PCL's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(45.35-0)/600.000
=0.08

Bangkok Genomics Innovation PCL's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(26.007-0)/600.000
=0.04

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ฿0.08 mean?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a EPS (Basic) of ฿0.08 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Bangkok Genomics Innovation PCL and its competitors.
Is Bangkok Genomics Innovation PCL's EPS (Basic) too high?
Bangkok Genomics Innovation PCL's current EPS (Basic) is ฿0.08. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's EPS (Basic) compare to TMO and DHR?
Bangkok Genomics Innovation PCL's EPS (Basic) of ฿0.08 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Diagnostics & Research company?
A good EPS (Basic) depends on the Medical Diagnostics & Research industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Bangkok Genomics Innovation PCL and its competitors. Bangkok Genomics Innovation PCL's current EPS (Basic) is ฿0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current EPS (Basic) of ฿0.08. The current EPS (Basic) is ฿0.08. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current EPS (Basic) is ฿0.08 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bangkok Genomics Innovation PCL Business Description

Address 3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score

Get the complete analysis for BKK:BKGI

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿2.08
Price